Alpha 1-antitrypsin deficiency primary prevention: Difference between revisions
Mazia Fatima (talk | contribs) |
Mazia Fatima (talk | contribs) |
||
| Line 9: | Line 9: | ||
==Primary Prevention== | ==Primary Prevention== | ||
Effective measures for the primary prevention of alpha 1-antitrypsin deficiency include: | Effective measures for the primary prevention of alpha 1-antitrypsin deficiency include:<ref name="pmid16236846">{{cite journal |vauthors=Stoller JK, Sandhaus RA, Turino G, Dickson R, Rodgers K, Strange C |title=Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem |journal=Chest |volume=128 |issue=4 |pages=1989–94 |year=2005 |pmid=16236846 |doi=10.1378/chest.128.4.1989 |url=}}</ref> | ||
*Vaccination against hepatitis A and B is recommended to decrease the risk of liver disease. | *Vaccination against hepatitis A and B is recommended to decrease the risk of liver disease. | ||
Revision as of 01:18, 16 December 2017
|
Alpha 1-antitrypsin deficiency Microchapters |
|
Differentiating Alpha 1-antitrypsin deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Alpha 1-antitrypsin deficiency primary prevention On the Web |
|
American Roentgen Ray Society Images of Alpha 1-antitrypsin deficiency primary prevention |
|
Alpha 1-antitrypsin deficiency primary prevention in the news |
|
Directions to Hospitals Treating Alpha 1-antitrypsin deficiency |
|
Risk calculators and risk factors for Alpha 1-antitrypsin deficiency primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Effective measures for the primary prevention of alpha 1-antitrypsin deficiency includes vaccination against hepatitis A and B is recommended to decrease the risk of liver disease.
Primary Prevention
Effective measures for the primary prevention of alpha 1-antitrypsin deficiency include:[1]
- Vaccination against hepatitis A and B is recommended to decrease the risk of liver disease.
References
- ↑ Stoller JK, Sandhaus RA, Turino G, Dickson R, Rodgers K, Strange C (2005). "Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem". Chest. 128 (4): 1989–94. doi:10.1378/chest.128.4.1989. PMID 16236846.